Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Cain

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bone|May 10, 2001
Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbitsT Mashiba, D B Burr, C H Turner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2000
Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893A F Stewart, R L Cain, D B Burr, et al.
The American Journal of Psychiatry|May 1, 1989
Perinatal loss and parental bereavementS K Theut, F A Pedersen, M J Zaslow, et al.
Journal of Neuroimmunology|September 1, 1989
Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alphaL D Butler, N K Layman, P E Riedl, et al.
Immunopharmacology and Immunotoxicology|January 1, 1989
Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic interventionL D Butler, K M Mohler, N K Layman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 5, 1999
Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in ratsC A Frolik, R L Cain, M Sato, et al.
Calcified Tissue International|August 3, 1999
Molecular characterization of gene expression changes in ROS 17/2.8 cells cultured in diffusion chambers in vivoJ E Onyia, L V Hale, R R Miles, et al.
Endocrinology|August 23, 2001
Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formationY L Ma, R L Cain, D L Halladay, et al.
Clinical Immunology and Immunopathology|December 1, 1989
Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic interventionL D Butler, N K Layman, R L Cain, et al.
Bone|July 29, 2000
In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragmentD Stanislaus, X Yang, J D Liang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bone|May 10, 2001
Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbitsT Mashiba, D B Burr, C H Turner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2000
Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893A F Stewart, R L Cain, D B Burr, et al.
The American Journal of Psychiatry|May 1, 1989
Perinatal loss and parental bereavementS K Theut, F A Pedersen, M J Zaslow, et al.
Journal of Neuroimmunology|September 1, 1989
Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alphaL D Butler, N K Layman, P E Riedl, et al.
Immunopharmacology and Immunotoxicology|January 1, 1989
Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic interventionL D Butler, K M Mohler, N K Layman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 5, 1999
Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in ratsC A Frolik, R L Cain, M Sato, et al.
Calcified Tissue International|August 3, 1999
Molecular characterization of gene expression changes in ROS 17/2.8 cells cultured in diffusion chambers in vivoJ E Onyia, L V Hale, R R Miles, et al.
Endocrinology|August 23, 2001
Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formationY L Ma, R L Cain, D L Halladay, et al.
Clinical Immunology and Immunopathology|December 1, 1989
Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic interventionL D Butler, N K Layman, R L Cain, et al.
Bone|July 29, 2000
In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragmentD Stanislaus, X Yang, J D Liang, et al.
Pageof 3